Modulation of cellular proliferation alters glutamine transport and metabolism in human hepatoma cells.

Por Bode, B P, Souba, W W
Publicado em 1994

Adaptive alterations in cellular metabolism with malignant transformation.

Por Fischer, C P, Bode, B P, Souba, W W
Publicado em 1998

A sarcoma-derived protein regulates hepatocyte metabolism via autocrine production of tumor necrosis factor-alpha.

Por Fischer, C P, Bode, B P, Souba, W W
Publicado em 1996

Uncommon case of brain metastasis in a patient with a history of heavy smoking

Por Scharl, M., Bode, B., Rushing, E., Knuth, A., Rordorf, T.
Publicado em 2014

Knotted fields and explicit fibrations for lemniscate knots

Por Bode, B., Dennis, M. R., Foster, D., King, R. P.
Publicado no Proc Math Phys Eng Sci (2017)

Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiri...

Por Garber, A, Henry, R R, Ratner, R, Hale, P, Chang, C T, Bode, B
Publicado em 2011

Efficacy and safety of once‐daily insulin degludec/insulin aspart compared with once‐daily insulin glargine in participants with Type 2 diabetes: a randomized, treat‐to‐target stud...

Por Kumar, S., Jang, H. C., Demirağ, N. G., Skjøth, T. V., Endahl, L., Bode, B.
Publicado no Diabet Med (2016)

Normalization of tumor-induced increases in hepatic amino acid transport after surgical resection.

Por Espat, N J, Bode, B P, Lind, D S, Copeland, E M, Souba, W W
Publicado em 1995

Glucocorticoid-dependent induction of interleukin-6 receptor expression in human hepatocytes facilitates interleukin-6 stimulation of amino acid transport.

Por Fischer, C P, Bode, B P, Takahashi, K, Tanabe, K K, Souba, W W
Publicado em 1996

Effects of propofol and fentanyl on duodenal motility activity in pigs

Por Schnoor, J., Unger, J.K., Kuepper, T., Bode, B., Hofeditz, A., Silny, J., Rossaint, R.
Publicado em 2005

Efficacy and safety of an oral device to reduce food intake and promote weight loss

Por Ryan, D. H., Parkin, C. G., Longley, W., Dixon, J., Apovian, C., Bode, B.
Publicado no Obes Sci Pract (2017)

Glutamine as a regulator of DNA and protein biosynthesis in human solid tumor cell lines.

Por Wasa, M, Bode, B P, Abcouwer, S F, Collins, C L, Tanabe, K K, Souba, W W
Publicado em 1996

Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin‐naïve people with Type 2 diabetes: the DUAL...

Por Rodbard, H. W., Bode, B. W., Harris, S. B., Rose, L., Lehmann, L., Jarlov, H., Thurman, J.
Publicado no Diabet Med (2016)

Arginine transport in human liver. Characterization and effects of nitric oxide synthase inhibitors.

Por Inoue, Y, Bode, B P, Beck, D J, Li, A P, Bland, K I, Souba, W W
Publicado em 1993

Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with t...

Por Bode, B W, Testa, M A, Magwire, M, Hale, P M, Hammer, M, Blonde, L, Garber, A
Publicado em 2010

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials

Por Ratner, R E, Gough, S C L, Mathieu, C, Del Prato, S, Bode, B, Mersebach, H, Endahl, L, Zinman, B
Publicado em 2013

One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial...

Por Gough, S. C. L., Bode, B. W., Woo, V. C., Rodbard, H. W., Linjawi, S., Zacho, M., Reiter, P. D., Buse, J. B.
Publicado no Diabetes Obes Metab (2015)

Short Report: Treatment Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal–bolus treatment with mealtime insulin asp...

Por Bode, B W, Buse, J B, Fisher, M, Garg, S K, Marre, M, Merker, L, Renard, E, Russell-Jones, D L, Hansen, C T, Rana, A, Heller, S R
Publicado no Diabet Med (2013)